Choosing a revascularization strategy for your patient with CAD. Consider both the clinical presentation and the urgency of the situation.
For patients with less severe coronary artery disease, particularly one- or two-vessel disease, initial therapy may be with either thrombolytics or angioplasty. In those with more extensive disease (three-vessel or left main artery disease or proximal left anterior descending artery stenosis), bypass grafting can significantly reduce mortality. However, a patient's risk profile markedly influences outcome regardless of the procedure performed. Because angioplasty achieves incomplete revascularization, patients may need repeated angiography or revascularization, or they may have recurrent angina. If bypass graft disease is prevented, surgery may be effective for up to 20 years.
Aranki
S F
SF
Harvard Medical School, Boston, USA.
Cohn
L H
LH
D015906:Angioplasty, Balloon, Coronary / Q000191:economics; D001026:Coronary Artery Bypass / Q000191:economics; D003327:Coronary Disease / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003657:Decision Making; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D015996:Survival Rate